{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:17:54Z","timestamp":1793643474028,"version":"4.5.1"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.brainresbull.2023.110673","type":"journal-article","created":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T11:31:33Z","timestamp":1685359893000},"page":"110673","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Advances in stem cell and other therapies for Huntington\u2019s disease: An update"],"prefix":"10.1016","volume":"199","author":[{"given":"LT","family":"Conner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Srinageshwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JL","family":"Bakke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GL","family":"Dunbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Rossignol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainresbull.2023.110673_bib1","first-page":"1","article-title":"Recent advances in the generation of \u03b2-cells from induced pluripotent stem cells as a potential cure for diabetes mellitus. Cell Biology and Translational Medicine","volume":"Volume 14","author":"Agrawal","year":"2021","journal-title":"Stem Cells Linea Specif. Differ. Dis."},{"key":"10.1016\/j.brainresbull.2023.110673_bib2","first-page":"1073","article-title":"Therapeutic potential of stem cells for treatment of neurodegenerative diseases","volume":"Vol. 42","author":"Ahmadian-Moghadam","year":"2020"},{"issue":"12","key":"10.1016\/j.brainresbull.2023.110673_bib3","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1016\/j.ymthe.2021.04.008","article-title":"Gene therapy for ALS: a review","volume":"29","author":"Amado","year":"2021","journal-title":"Mol. Ther."},{"issue":"7","key":"10.1016\/j.brainresbull.2023.110673_bib4","doi-asserted-by":"crossref","first-page":"2002944","DOI":"10.1002\/advs.202002944","article-title":"Mesenchymal stem cells for neurological disorders","volume":"8","author":"Andrzejewska","year":"2021","journal-title":"Adv. Sci."},{"issue":"7","key":"10.1016\/j.brainresbull.2023.110673_bib5","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","article-title":"Genome editing with CRISPR\u2013Cas nucleases, base editors, transposases and prime editors","volume":"38","author":"Anzalone","year":"2020","journal-title":"Nat. Biotechnol."},{"issue":"12","key":"10.1016\/j.brainresbull.2023.110673_bib6","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.3390\/cells9122663","article-title":"Stem cell-derived exosomes as therapeutic approach for neurodegenerative disorders: from biology to biotechnology","volume":"9","author":"Araldi","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.brainresbull.2023.110673_bib7","unstructured":"Azidus Brasil. (2022a). Clinical Extension Study for Assessing the Safety and Efficacy of the Intravenous Administration of Cellavita-HD in Huntington\u2019s Disease Patients Who Participated in the ADORE-DH Study. (Clinical Trial Registration No. NCT04219241). clinicaltrials.gov. \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04219241\u3009."},{"key":"10.1016\/j.brainresbull.2023.110673_bib8","unstructured":"Azidus Brasil. (2022b). Dose-Response Evaluation of the Investigational Product Cellavita HD After Intravenous Administration in Patients With Huntington\u2019s Disease (Clinical Trial Registration No. NCT03252535). clinicaltrials.gov. \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03252535\u3009."},{"key":"10.1016\/j.brainresbull.2023.110673_bib9","unstructured":"Azidus Brasil. (2022c). First in Human Study to Evaluate Safety of Cellavita HD Investigational Product After Intravenous Application in Participants With Huntington\u2019s Disease (Clinical Trial Registration No. NCT02728115). clinicaltrials.gov. \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02728115\u3009."},{"issue":"2","key":"10.1016\/j.brainresbull.2023.110673_bib10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/stem.3300","article-title":"Cell therapy in Huntington\u2019s disease: taking stock of past studies to move the field forward","volume":"39","author":"Bachoud-L\u00e9vi","year":"2021","journal-title":"Stem Cells"},{"issue":"8","key":"10.1016\/j.brainresbull.2023.110673_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/mds.28201","article-title":"Human fetal cell therapy in Huntington\u2019s Disease: a randomized, multicenter, phase II trial","volume":"35","author":"Bachoud-L\u00e9vi","year":"2020","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"issue":"4","key":"10.1016\/j.brainresbull.2023.110673_bib12","doi-asserted-by":"crossref","first-page":"NS20210019","DOI":"10.1042\/NS20210019","article-title":"Do foetal transplant studies continue to be justified in Huntington\u2019s disease?","volume":"5","author":"Bartley","year":"2021","journal-title":"Neuron. Signal"},{"issue":"3","key":"10.1016\/j.brainresbull.2023.110673_bib13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.stem.2020.08.013","article-title":"Are organoids ready for prime time","volume":"27","author":"Bhaduri","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"51","key":"10.1016\/j.brainresbull.2023.110673_bib14","doi-asserted-by":"crossref","first-page":"15672","DOI":"10.1073\/pnas.1520760112","article-title":"Human cerebral organoids recapitulate gene expression programs of fetal neocortex development","volume":"112","author":"Camp","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.brainresbull.2023.110673_bib15","first-page":"36","article-title":"Potent and sustained huntingtin lowering via AAV5 encoding miRNA preserves striatal volume and cognitive function in a humanized mouse model of Huntington disease","volume":"48","author":"Caron","year":"2020","journal-title":"Nucleic acids research"},{"key":"10.1016\/j.brainresbull.2023.110673_bib16","unstructured":"Caron NS, Wright GEB, Hayden MR. Huntington Disease. 1998 Oct 23 [Updated 2020 Jun 11]. In: Adam MP, Mirzaa GM, Pagon RA, et al., editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2023. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1305."},{"issue":"4","key":"10.1016\/j.brainresbull.2023.110673_bib17","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.stem.2019.09.002","article-title":"Transplantation of human brain organoids: revisiting the science and ethics of brain chimeras","volume":"25","author":"Chen","year":"2019","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.brainresbull.2023.110673_bib18","doi-asserted-by":"crossref","first-page":"C151","DOI":"10.1152\/ajpcell.00120.2020","article-title":"A brief history of organoids","volume":"319","author":"Corr\u00f2","year":"2020","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"Issue 6","key":"10.1016\/j.brainresbull.2023.110673_bib19","article-title":"Recent overview of the use of iPSCs huntington\u2019s disease modeling and therapy","volume":"Vol. 21","author":"Csobonyeiova","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"Issue 9","key":"10.1016\/j.brainresbull.2023.110673_bib20","article-title":"Neural stem cell transplantation for neurodegenerative diseases","volume":"Vol. 21","author":"De Gioia","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.brainresbull.2023.110673_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaa230","article-title":"Protocol for an open label: phase I trial within a cohort of foetal cell transplants in people with Huntington\u2019s disease","volume":"3","author":"Drew","year":"2021","journal-title":"Brain Commun."},{"issue":"23","key":"10.1016\/j.brainresbull.2023.110673_bib22","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1002\/1873-3468.13656","article-title":"Take the shortcut - direct conversion of somatic cells into induced neural stem cells and their biomedical applications","volume":"593","author":"Erharter","year":"2019","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.brainresbull.2023.110673_bib23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3233\/JHD-229002","article-title":"Huntington\u2019s disease clinical trials corner: April 2022","volume":"11","author":"Estevez-Fraga","year":"2022","journal-title":"J. Huntington\u2019s Dis."},{"issue":"1","key":"10.1016\/j.brainresbull.2023.110673_bib24","article-title":"Haplotyping SNPs for allele-specific gene editing of the expanded huntingtin allele using long-read sequencing","volume":"4","author":"Fang","year":"2023","journal-title":"Hum. Genet. Genom. Adv."},{"issue":"1","key":"10.1016\/j.brainresbull.2023.110673_bib25","first-page":"65","article-title":"Compartmentalized devices as tools for investigation of human brain network dynamics","volume":"248","author":"Fantuzzo","year":"2019","journal-title":"Dev. Dyn. Off. Publ. Am. Assoc. Anat."},{"issue":"7","key":"10.1016\/j.brainresbull.2023.110673_bib26","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1007\/s12035-021-02324-x","article-title":"Stem cell-derived exosomes: a new strategy of neurodegenerative disease treatment","volume":"58","author":"Fayazi","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.brainresbull.2023.110673_bib27","article-title":"Gene targeting techniques for Huntington\u2019s disease","volume":"Vol. 70","author":"Fields","year":"2021"},{"key":"10.1016\/j.brainresbull.2023.110673_bib28","series-title":"International Review of Neurobiology","article-title":"Challenges in progressing cell therapies to the clinic for Huntington\u2019s disease: a review of the progress made with pluripotent stem cell derived medium spiny neurons","author":"Garcia Jare\u00f1o","year":"2022"},{"key":"10.1016\/j.brainresbull.2023.110673_bib29","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fcell.2020.00149","article-title":"Mesenchymal stem cell- derived extracellular vesicles: challenges in clinical applications","volume":"8","author":"Gowen","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.brainresbull.2023.110673_bib30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fbioe.2019.00039","article-title":"Engineering organoid vascularization","volume":"7","author":"Grebenyuk","year":"2019","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"2","key":"10.1016\/j.brainresbull.2023.110673_bib31","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/s12035-021-02638-w","article-title":"CRISPR-Cas9-mediated gene therapy in neurological disorders","volume":"59","author":"Guan","year":"2022","journal-title":"Mol. Neurobiol."},{"issue":"16","key":"10.1016\/j.brainresbull.2023.110673_bib32","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1007\/s00018-011-0689-3","article-title":"Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles","volume":"68","author":"Gy\u00f6rgy","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.brainresbull.2023.110673_bib33","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1590\/s1980-5764-2016dn1004006","article-title":"Cell-based technologies for Huntington\u2019s disease","volume":"10","author":"Haddad","year":"2016","journal-title":"Dement. Neuropsychol."},{"issue":"6","key":"10.1016\/j.brainresbull.2023.110673_bib34","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1242\/dev.150201","article-title":"The hope and the hype of organoid research","volume":"144","author":"Huch","year":"2017","journal-title":"Development"},{"key":"10.1016\/j.brainresbull.2023.110673_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.695937","article-title":"Current and future prospects for gene therapy for rare genetic diseases affecting the brain and spinal cord","volume":"14","author":"Jensen","year":"2021","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.brainresbull.2023.110673_bib36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s43556-022-00072-5","article-title":"Enhancing prime editing via inhibition of mismatch repair pathway","volume":"3","author":"Jiang","year":"2022","journal-title":"Mol. Biomed."},{"issue":"6096","key":"10.1016\/j.brainresbull.2023.110673_bib37","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA\u2013guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.brainresbull.2023.110673_bib38","article-title":"A novel culture model for human pluripotent stem cell propagation on gelatin in placenta-conditioned media","volume":"102","author":"Jung","year":"2015","journal-title":"J. Vis. Exp."},{"issue":"Issue 8","key":"10.1016\/j.brainresbull.2023.110673_bib39","article-title":"Therapeutic strategies in huntington\u2019s disease: from genetic defect to gene therapy","volume":"Vol. 10","author":"Jurcau","year":"2022","journal-title":"Biomedicines"},{"issue":"17","key":"10.1016\/j.brainresbull.2023.110673_bib40","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.3390\/ijms21176240","article-title":"CRISPR-Cas9 DNA base-editing and prime-editing","volume":"21","author":"Kantor","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.brainresbull.2023.110673_bib41","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3390\/cells11030517","article-title":"Advances in modeling polyglutamine diseases using genome editing tools","volume":"11","author":"Karwacka","year":"2022","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.brainresbull.2023.110673_bib42","first-page":"405","article-title":"Experimental limitations of extracellular vesicle-based therapies for the treatment of myocardial infarction","volume":"31","author":"Kennedy","year":"2021","journal-title":"Trends Cardiovasc. Med."},{"issue":"2","key":"10.1016\/j.brainresbull.2023.110673_bib43","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.stem.2021.01.005","article-title":"Biphasic activation of WNT signaling facilitates the derivation of midbrain dopamine neurons from hESCs for translational use","volume":"28","author":"Kim","year":"2021","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10.1016\/j.brainresbull.2023.110673_bib44","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/d41573-021-00088-6","article-title":"Double setback for ASO trials in Huntington disease","volume":"20","author":"Kingwell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.brainresbull.2023.110673_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep16647","article-title":"Long-term maintenance of human induced pluripotent stem cells by automated cell culture system","volume":"5","author":"Konagaya","year":"2015","journal-title":"Sci. Rep."},{"issue":"Issue 1","key":"10.1016\/j.brainresbull.2023.110673_bib46","article-title":"Therapeutic advances for huntington\u2019s disease","volume":"Vol. 10","author":"Kumar","year":"2020","journal-title":"Brain Sci."},{"issue":"10","key":"10.1016\/j.brainresbull.2023.110673_bib47","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1038\/nprot.2014.158","article-title":"Generation of cerebral organoids from human pluripotent stem cells","volume":"9","author":"Lancaster","year":"2014","journal-title":"Nat. Protoc."},{"issue":"7","key":"10.1016\/j.brainresbull.2023.110673_bib48","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nbt.3906","article-title":"Guided self-organization and cortical plate formation in human brain organoids","volume":"35","author":"Lancaster","year":"2017","journal-title":"Nat. Biotechnol."},{"issue":"22","key":"10.1016\/j.brainresbull.2023.110673_bib49","doi-asserted-by":"crossref","first-page":"13936","DOI":"10.3390\/ijms232213936","article-title":"The bHLH transcription factors in neural development and therapeutic applications for neurodegenerative diseases","volume":"23","author":"Lee","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.brainresbull.2023.110673_bib50","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1016\/j.celrep.2016.12.001","article-title":"Cerebral organoids recapitulate epigenomic signatures of the human fetal brain","volume":"17","author":"Luo","year":"2016","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.brainresbull.2023.110673_bib51","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41587-021-01039-7","article-title":"Engineered pegRNAs improve prime editing efficiency","volume":"40","author":"Nelson","year":"2022","journal-title":"Nat. Biotechnol."},{"issue":"11","key":"10.1016\/j.brainresbull.2023.110673_bib52","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1016\/j.ymthe.2021.09.002","article-title":"In vivo somatic cell base editing and prime editing","volume":"29","author":"Newby","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.brainresbull.2023.110673_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.626755","article-title":"MSCs and inflammatory cells crosstalk in regenerative medicine: concerted actions for optimized resolution driven by energy metabolism","volume":"12","author":"Planat-Benard","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.brainresbull.2023.110673_bib54","article-title":"Brain organoids: Advances, applications and challenges","volume":"Vol. 146","author":"Qian","year":"2019"},{"issue":"7652","key":"10.1016\/j.brainresbull.2023.110673_bib55","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nature22047","article-title":"Cell diversity and network dynamics in photosensitive human brain organoids","volume":"545","author":"Quadrato","year":"2017","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.brainresbull.2023.110673_bib56","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1007\/s12015-021-10200-3","article-title":"An overview on promising somatic cell sources utilized for the efficient generation of induced pluripotent stem cells","volume":"17","author":"Ray","year":"2021","journal-title":"Stem Cell Rev. Rep."},{"issue":"4","key":"10.1016\/j.brainresbull.2023.110673_bib57","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.2217\/rme-2019-0119","article-title":"Umbilical cord-derived mesenchymal stem cells in neurodegenerative disorders: from literature to clinical practice","volume":"15","author":"Reyhani","year":"2020","journal-title":"Regen. Med."},{"issue":"3","key":"10.1016\/j.brainresbull.2023.110673_bib58","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/mds.28503","article-title":"Cell therapy for Huntington\u2019s Disease: learning from failure","volume":"36","author":"Rosser","year":"2021","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"issue":"8b","key":"10.1016\/j.brainresbull.2023.110673_bib59","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1111\/j.1582-4934.2008.00657.x","article-title":"Mesenchymal stem cells induce a weak immune response in the rat striatum after allo or xenotransplantation","volume":"13","author":"Rossignol","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.brainresbull.2023.110673_bib60","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.reth.2022.09.001","article-title":"Pathogenesis and potential therapeutic application of stem cells transplantation in Huntington\u2019s disease","volume":"21","author":"Saha","year":"2022","journal-title":"Regen. Ther."},{"key":"10.1016\/j.brainresbull.2023.110673_bib61","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.reth.2022.09.001","article-title":"Pathogenesis and potential therapeutic application of stem cells transplantation in Huntington\u2019s disease","volume":"21","author":"Saha","year":"2022","journal-title":"Regen. Ther."},{"issue":"7\u20138","key":"10.1016\/j.brainresbull.2023.110673_bib62","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41434-021-00263-9","article-title":"Prime editing\u2013an update on the field","volume":"28","author":"Scholefield","year":"2021","journal-title":"Gene Ther."},{"issue":"5","key":"10.1016\/j.brainresbull.2023.110673_bib63","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s12640-022-00564-w","article-title":"CRISPR and iPSCs: recent developments and future perspectives in neurodegenerative disease modelling, research, and therapeutics","volume":"40","author":"Sen","year":"2022","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.brainresbull.2023.110673_bib64","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.omtm.2022.08.005","article-title":"PAM-altering SNP-based allele-specific CRISPR-Cas9 therapeutic strategies for Huntington\u2019s disease","volume":"26","author":"Shin","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"Issue 4","key":"10.1016\/j.brainresbull.2023.110673_bib65","first-page":"1","article-title":"Regenerative stem cell therapy for neurodegenerative diseases: an overview","volume":"Vol. 22","author":"Sivandzade","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.brainresbull.2023.110673_bib66","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202000707","article-title":"Robust production of uniform human cerebral organoids from pluripotent stem cells","volume":"3","author":"Sivitilli","year":"2020","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.brainresbull.2023.110673_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2021.107737","article-title":"Paving the way towards precise and safe CRISPR genome editing","volume":"49","author":"Sledzinski","year":"2021","journal-title":"Biotechnol. Adv."},{"issue":"5","key":"10.1016\/j.brainresbull.2023.110673_bib68","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/sctm.19-0248","article-title":"Prion-like mechanisms in neurodegenerative disease: implications for Huntington\u2019s disease therapy","volume":"9","author":"Srinageshwar","year":"2020","journal-title":"Stem Cells Transl. Med."},{"issue":"1","key":"10.1016\/j.brainresbull.2023.110673_bib69","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00467-017-3816-z","article-title":"Exosomes and microvesicles in normal physiology, pathophysiology, and renal diseases","volume":"34","author":"St\u00e5hl","year":"2019","journal-title":"Pediatr. Nephrol."},{"issue":"Issue 1","key":"10.1016\/j.brainresbull.2023.110673_bib70","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/practneurol-2021-003074","article-title":"Huntington\u2019s disease: diagnosis and management","volume":"Vol. 22","author":"Stoker","year":"2022","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.brainresbull.2023.110673_bib71","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/5584_2021_660","article-title":"Tissue-restricted stem cells as starting cell source for efficient generation of pluripotent stem cells: an overview","volume":"1376","author":"Sundaravadivelu","year":"2022","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"10.1016\/j.brainresbull.2023.110673_bib72","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.stem.2021.01.013","article-title":"Clinical trial for Parkinson\u2019s disease gets a green light in the US","volume":"28","author":"Takahashi","year":"2021","journal-title":"Cell Stem Cell"},{"issue":"s2","key":"10.1016\/j.brainresbull.2023.110673_bib73","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.3233\/JPD-212685","article-title":"Bringing advanced therapies for Parkinson\u2019s disease to the clinic: The Scientist\u2019s Perspective","volume":"11","author":"Tomishima","year":"2021","journal-title":"Journal of Parkinson's Disease"},{"issue":"1","key":"10.1016\/j.brainresbull.2023.110673_bib74","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s12035-021-02603-7","article-title":"Insights of extracellular vesicles of mesenchymal stem cells: a prospective cell-free regenerative medicine for neurodegenerative disorders","volume":"59","author":"Vatsa","year":"2022","journal-title":"Mol. Neurobiol."},{"issue":"7762","key":"10.1016\/j.brainresbull.2023.110673_bib75","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41586-019-1289-x","article-title":"Individual brain organoids reproducibly form cell diversity of the human cerebral cortex","volume":"570","author":"Velasco","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.brainresbull.2023.110673_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41378-020-00185-3","article-title":"Microtechnology-based methods for organoid models","volume":"6","author":"Velasco","year":"2020","journal-title":"Microsyst. Nanoeng."},{"issue":"2","key":"10.1016\/j.brainresbull.2023.110673_bib77","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s12015-020-10068-9","article-title":"Modeling neurodegenerative diseases with cerebral organoids and other three-dimensional culture systems: focus on Alzheimer\u2019s disease","volume":"18","author":"Venkataraman","year":"2022","journal-title":"Stem Cell Rev. Rep."},{"issue":"118","key":"10.1016\/j.brainresbull.2023.110673_bib78","article-title":"Mesenchymal stem cells-derived exosomes: a new possible therapeutic strategy for Parkinson\u2019s Disease","volume":"8(2)","author":"Vila\u00e7a-Faria","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.brainresbull.2023.110673_bib79","first-page":"4","article-title":"Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting","author":"Wiklander","year":"2015","journal-title":"J. Extracell. Vesicles"},{"issue":"11","key":"10.1016\/j.brainresbull.2023.110673_bib80","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/bioengineering9110662","article-title":"Mesenchymal stem cells and mscs-derived extracellular vesicles in infectious diseases: from basic research to clinical practice","volume":"9","author":"Yudintceva","year":"2022","journal-title":"Bioengineering"},{"issue":"21","key":"10.1016\/j.brainresbull.2023.110673_bib81","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.3390\/cells11213476","article-title":"Stem-cell-based therapy: the celestial weapon against neurological disorders","volume":"11","author":"Zayed","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.brainresbull.2023.110673_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.31083\/j.jin.2020.01.1142","article-title":"Neural stem cell secretome and its role in the treatment of neurodegenerative disorders","volume":"19","author":"Zhang","year":"2020","journal-title":"J. Integr. Neurosci."},{"key":"10.1016\/j.brainresbull.2023.110673_bib83","doi-asserted-by":"crossref","first-page":"179","DOI":"10.31083\/j.jin.2020.01.1142","article-title":"Neuralstem cell secretome and its role in the treatment of neurodegenerative disorders","volume":"19(1)","author":"Zhang","year":"2020","journal-title":"J. Integr. Neurosci."}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923023001053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923023001053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:56:21Z","timestamp":1759784181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923023001053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":83,"alternative-id":["S0361923023001053"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2023.110673","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in stem cell and other therapies for Huntington\u2019s disease: An update","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2023.110673","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110673"}}